|
|
Title | Creator | Date |
| 126 |
 |
What is the Current Status of Optic Nerve Sheath Fenestration? | James A. Garrity, MD | 2016-09 |
| 127 |
 |
Weighing the Risks and Benefits of Antidepressants in Idiopathic Intracranial Hypertension | Anna M. Gruener, BMedSci(Hons), BMBS, MSc, FRCOphth, Alexander D. Jolly, BMBS, MRCPsych, James M. A. Ellison, BMedSci(Hons), BMBS, PGDip, MRCPsych, Michael A. Burdon, MBBS, FRCP, FRCOphth | 2018-03 |
| 128 |
 |
What Do We Really Know About Translaminar Pressure? | Hanspeter E. Killer, MD, Achmed Pircher, MD | 2016-03 |
| 129 |
 |
What Do We Really Know About Translaminar Pressure?: Response | Timothy J. McCulley, MD, Jessica R. Chang, MD, Christopher R. Monroe, PhD | 2016-03 |
| 130 |
 |
Vanishing Act - Gorham-Stout Disease Leading to Dynamic Cerebrospinal Fluid Abnormalities | Jason H. Peragallo, Bruno P. Soares | 2018-09 |
| 131 |
 |
Images in Neuro-Ophthalmology | Alex McGaughy MD, Michael Vaphiades DO, Lanning Kline MD | 2018-09 |
| 132 |
 |
Journal of Neuro-Ophthalmology, March 2000, Volume 20, Issue 1 | | 2000-03 |
| 133 |
 |
The Use of Acetazolamide During Pregnancy in Intracranial Hypertension Patients | Julie Falardeau, MD, Brenna M. Lobb, MS, MPH, Sara Golden, MPH, Steven D. Maxfield, BS, Emanuel Tanne, MD | 2013-03 |
| 134 |
 |
Optical Coherence Tomography Should Be Used Routinely to Monitor Patients With Idiopathic Intracranial Hypertension | John J. Chen, MD, PhD, Jonathan D. Trobe, MD | 2016-12 |
| 135 |
 |
Optical Coherence Tomography in Optic Nerve Hypoplasia: Correlation With Optic Disc Diameter, Nerve Fiber Layer Thickness, and Visual Function | John P. Kelly, PhD, Francine Baran, MD, James O. Phillips, PhD, Avery H. Weiss, MD | 2018-09 |
| 136 |
 |
Congenital Oculomotor Nerve Paresis With Isolated Cyclic Pupillary Spasms | Michael S. Salman, MBBS, BSc, MRCP, MSc, PhD, Samantha F. Klassen, BSc, MD,Ian H. Clark, MA, MB BChir, FRCSEd, FRCSC | 2015-12 |
| 137 |
 |
Congenital Achiasma | Augustin Lecler, MD, MSc, Arnaud Attye, MD, Catherine Edelson, MD | 2018-09 |
| 138 |
 |
Role of Endoscopic Skull Base and Keyhole Surgery for Pituitary and Parasellar Tumors Impacting Vision: Erratum | | 2016-03 |
| 139 |
|
Physiological Correlates and Predictors of Functional Recovery After Chiasmal Decompression: Erratum | | 2016-03 |
| 140 |
 |
Acknowledgment of Reviewers | | 2016-06 |
| 141 |
 |
Validity and Acceptance of Color Vision Testing on Smartphones | Omar K. Ozgur; Trisha S. Emborgo; Mark B. Vieyra; Rebecca F. Huselid; Rudrani Banik | 2018-03 |
| 142 |
 |
New Ways of "Seeing" the Mechanistic Heterogeneity of Multiple Sclerosis Plaque Pathogenesis | Ethan I. Meltzer; Fiona E. Costello; Elliot M. Frohman; Teresa C. Frohman | 2018-03 |
| 143 |
 |
Validity of Forced Eyelid Closure Test: A Novel Clinical Screening Test for Ocular Myasthenia Gravis. | Apinyawasisuk, Supanut; Zhou, Xinkai; Tian, Jack J; Garcia, Giancarlo A; Karanjia, Rustum; Sadun, Alfredo A | 2017-09 |
| 144 |
 |
Does Dolichoectasia of the Carotid Artery Cause Optic Neuropathy? | Valerie I. Elmalem, MD, Valerie A. Purvin, MD | 2018-09 |
| 145 |
 |
Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients? | Sui H. Wong, MRCP, Gordon T. Plant, FRCP, FRCOphth, Wayne Cornblath, MD | 2016-03 |
| 146 |
 |
Does Nocturnal Hypotension Play a Causal Role in Nonarteritic Anterior Ischemic Optic Neuropathy? | Dean M. Cestari, MD, Anthony Arnold, MD | 2016-09 |
| 147 |
 |
Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase Antibodies | Ana I. Martins, MD, João N. Carvalho, MD, Ana M. Amorim, MD, Argemiro Geraldo, MD,Eric Eggenberger, DO, MSEpi, João Lemos, MD | 2018-03 |
| 148 |
 |
Editor's Corner | Ronald M. Burde, MD | 1994-06 |
| 149 |
 |
Editorial | Ronald M. Burde, MD | 1994-03 |
| 150 |
 |
Factors Associated With Lack of Vision Improvement in Children With Cortical Visual Impairment | Swati Handa, FRCS, MCI, Seyed E. Saffari, PhD, Mark Borchert, MD | 2018-12 |
